moose, I'm the same guy who was talking (and mentioned to Stoll) $100 -- you're paying attention -- mark one down for the moosedogger -- but that's if the high impacts are so disease-modifying that they reverse the effects of Alzheimer's, cure sz, etc., -- then COR really is a goldmine, as Roger himself put it.
I'm talking near future, short-term for the stock, and I think it'll retrace significantly from here -- but if and when the dosing limitations are lifted, we should blow past even $4.50 with a BP deal.
The FDA decision is absolutely critical re the price of the stock.